nobiletin has been researched along with Insulin Resistance in 7 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 6 (85.71) | 24.3611 |
| 2020's | 1 (14.29) | 2.80 |
| Authors | Studies |
|---|---|
| Matveyenko, AV; Rakshit, K | 1 |
| Guo, R; Li, L; Liu, H; Liu, X; Mi, Y; Qi, G; Tian, H | 1 |
| Choi, MS; Jeong, MJ; Jung, UJ; Kim, SR; Kim, YJ; Woo, JT | 1 |
| Cha, BY; Choi, SS; Lee, YS; Nagai, K; Saito, K; Teruya, T; Woo, JT; Yamaguchi, K; Yamakawa, H; Yonezawa, T | 1 |
| Ito, A; Kosano, H; Miyata, Y; Sato, T; Shimada, A; Tanaka, H; Yamanouchi, T | 1 |
| Allister, EM; Assini, JM; Charbonneau, A; Edwards, JY; Huff, MW; Koppes, JB; Lee, JK; Marette, A; Mulvihill, EE; Sawyez, CG; St-Pierre, P; Sutherland, BG; Telford, DE | 1 |
| Cha, BY; Choi, BK; Choi, SS; Lee, YS; Nagai, K; Teruya, T; Woo, JT; Yonezawa, T | 1 |
7 other study(ies) available for nobiletin and Insulin Resistance
| Article | Year |
|---|---|
Induction of Core Circadian Clock Transcription Factor Bmal1 Enhances β-Cell Function and Protects Against Obesity-Induced Glucose Intolerance.
Topics: Animals; ARNTL Transcription Factors; Blood Glucose; Circadian Clocks; Circadian Rhythm; Flavones; Glucose; Glucose Intolerance; Humans; Insulin; Insulin Resistance; Insulin-Secreting Cells; Islets of Langerhans; Male; Mice; Mice, Transgenic; Motor Activity; Obesity | 2021 |
Nobiletin protects against insulin resistance and disorders of lipid metabolism by reprogramming of circadian clock in hepatocytes.
Topics: AMP-Activated Protein Kinases; Circadian Clocks; Flavones; Hep G2 Cells; Hepatocytes; Humans; Insulin Receptor Substrate Proteins; Insulin Resistance; Lipid Metabolism; Proto-Oncogene Proteins c-akt; Signal Transduction | 2018 |
Long-term dietary supplementation with low-dose nobiletin ameliorates hepatic steatosis, insulin resistance, and inflammation without altering fat mass in diet-induced obesity.
Topics: Adipose Tissue; Animals; Body Weight; Cytokines; Diet, High-Fat; Dietary Supplements; Dyslipidemias; Flavones; Hepatitis; Insulin Resistance; Lipids; Liver; Male; Mice, Inbred C57BL; Non-alcoholic Fatty Liver Disease; Obesity | 2017 |
Nobiletin improves hyperglycemia and insulin resistance in obese diabetic ob/ob mice.
Topics: Adipokines; Adipose Tissue, White; Animals; Antioxidants; Flavones; Gene Expression Regulation; Glucose Transporter Type 1; Glucose Transporter Type 4; Hyperglycemia; Insulin Resistance; Mice; Mice, Obese; Muscles | 2010 |
Regulation of adipocytokine secretion and adipocyte hypertrophy by polymethoxyflavonoids, nobiletin and tangeretin.
Topics: 3T3-L1 Cells; Adipocytes; Adipokines; Animals; Apoptosis; Blotting, Western; Cell Culture Techniques; Cell Differentiation; Cell Enlargement; Chemokine CCL2; Culture Media; Enzyme-Linked Immunosorbent Assay; Flavones; In Situ Nick-End Labeling; Insulin Resistance; Mice; Molecular Structure; Time Factors; Triglycerides | 2011 |
Nobiletin attenuates VLDL overproduction, dyslipidemia, and atherosclerosis in mice with diet-induced insulin resistance.
Topics: Animals; Atherosclerosis; Butadienes; Diet; Dyslipidemias; Electrophoresis, Polyacrylamide Gel; Energy Metabolism; Enzyme Inhibitors; Flavones; Hep G2 Cells; Humans; Insulin; Insulin Receptor Substrate Proteins; Insulin Resistance; Lipoproteins, VLDL; Male; MAP Kinase Kinase 1; MAP Kinase Kinase 2; Mice; Mice, Mutant Strains; Nitriles; Phosphorylation; Receptor, Insulin; Reverse Transcriptase Polymerase Chain Reaction; Signal Transduction; Triglycerides | 2011 |
Nobiletin improves obesity and insulin resistance in high-fat diet-induced obese mice.
Topics: Adipokines; Adiponectin; Adipose Tissue, White; Animals; Diet, High-Fat; Eating; Flavones; Gene Expression Regulation; Insulin; Insulin Resistance; Lipid Metabolism; Liver; Male; Mice; Mice, Inbred C57BL; Obesity; Organ Size; PPAR gamma; Triglycerides; Weight Gain | 2013 |